Production (Stage)
Cadrenal Therapeutics, Inc.
CVKD
$13.30
-$0.396-2.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -26.77% | 129.56% | -13.37% | -23.29% | -21.85% |
| Total Receivables | -35.34% | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1,260.76% | -77.93% | -18.39% | -20.05% | 460.69% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -40.97% | -87.68% | -31.80% | 2.15% | -- |
| Total Current Assets | -21.44% | 116.43% | -14.16% | -22.55% | -17.24% |
|
|
|||||
| Total Current Assets | -21.44% | 116.43% | -14.16% | -22.55% | -17.24% |
| Net Property, Plant & Equipment | -31.88% | 130.00% | -69.70% | -40.36% | -28.76% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | -21.44% | 116.35% | -14.25% | -22.58% | -17.27% |
|
|
|||||
| Total Accounts Payable | -14.92% | 202.44% | -34.59% | 89.69% | 139.33% |
| Total Accrued Expenses | -52.45% | 53.86% | 10.24% | 58.03% | -30.93% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -75.00% | -42.11% | -28.97% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -31.44% | 111.86% | -13.52% | 71.07% | 3.56% |
|
|
|||||
| Total Current Liabilities | -31.44% | 111.86% | -13.52% | 71.07% | 3.56% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -31.44% | 111.86% | -13.52% | 71.07% | 3.56% |
|
|
|||||
| Common Stock & APIC | 7.60% | 32.93% | 7.91% | 0.84% | 0.72% |
| Retained Earnings | -14.95% | -19.44% | -12.59% | -14.30% | -11.04% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -17.83% | 118.02% | -14.53% | -35.53% | -19.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -17.83% | 118.02% | -14.53% | -35.53% | -19.50% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -17.83% | 118.02% | -14.53% | -35.53% | -19.50% |
|
|
|||||